市場調查報告書
商品編碼
1380392
2023-2030 年全球顱骨穿孔器市場Global Cranial Perforators Market 2023-2030 |
預計在預測期內(2023-2030年),全球顱骨穿孔器市場將以 7.8% 的CAGR成長。由於腦腫瘤、腦外傷和腦出血等神經系統疾病的盛行率不斷上升,對顱腦手術的需求正在穩定增加,預計將大幅增加對顱穿血管器的需求。據世界衛生組織稱,約有 5000 萬人患有癲癇症,使其成為全球最常見的神經系統疾病之一。
全球顱骨穿孔器市場按類型和最終用戶進行細分。根據類型,市場分為可重複使用顱骨穿孔器和一次性顱骨穿孔器。此外,根據最終用戶,市場分為醫院和門診手術中心。其中,一次性顱骨穿孔器子細分市場預計將佔據相當大的市場佔有率,因為它消除了交叉污染和感染傳播的風險,與需要再處理的可重複使用顱骨穿孔器相比,節省了寶貴的手術室時間。
其中,醫院細分市場預計將在全球顱穿管市場中佔據相當大的佔有率。 2022 年,醫院細分市場佔據最大市場佔有率,達到 60.4%。這是由於神經系統疾病患者住院人數的增加。根據美國國家生物技術資訊中心 (NCBI) 的數據,每年有 2,260 萬人遭受神經損傷或疾病,其中 1,380 萬人需要手術治療。因此,神經科住院人數的增加增加了對手術所需設備的需求,從而推動了細分市場的成長。技術先進的顱骨穿孔器的可用性,加上有利的報銷政策,可以進一步促進預測期內的細分市場成長。
全球顱骨穿孔器市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本) 、韓國和亞洲其他地區),以及世界其他地區(中東和非洲以及拉丁美洲)。其中,由於技術的不斷發展,預計歐洲將在全球市場中佔據顯著佔有率。先進的顱穿支,加上優惠的報銷政策,導致需要手術的疾病的盛行率和發生率不斷上升。
在所有地區中,預計北美在預測期內將佔據顯著佔有率。市場成長歸因於神經系統疾病發生率的上升、外科技術的進步、老年人口的增加、神經外科手術的持續研發。此外,監管部門的批准、優惠的報銷政策和醫療保健基礎設施也大大促進了市場的擴張。據腦動脈瘤基金會稱,美國估計有 670 萬人患有未破裂的腦動脈瘤,即每 50 人中就有 1 人患有未破裂腦動脈瘤。腦動脈瘤破裂佔所有新興中風的 3-5%。該地區先進的醫學研究環境促進了醫療設備製造商、研究機構和醫療保健提供者之間的合作。這些合作夥伴關係推動了顱穿孔器的創新,重點是個人化醫療和患者專用儀器。
服務於全球顱骨穿孔器市場的主要公司包括: ACRA-CUT Inc.、American Surgical Co.、Integra LifeSciences Corp.、Nouvag AG、adeor Medical AG 等。市場參與者透過各種策略(包括併購、合作、合作、融資和新產品發布),為市場成長做出了巨大貢獻,以保持市場競爭力。例如,2020年10月,adeor Medical AG與IMEDCARE建立合作夥伴關係,透過Imedcare在澳洲獨家分銷產品。
Title: Global Cranial Perforators Market Size, Share & Trends Analysis Report by Type (Reusable cranial perforators and Disposable cranial perforators), by End-User (Hospitals and Ambulatory Surgical Centers),Forecast Period (2023-2030).
The global cranial perforators market is anticipated to grow at a CAGR of 7.8% during the Forecast Period (2023-2030). The demand for cranial surgeries is steadily increasing owing to the rising prevalence of neurological disorders, including brain tumors, traumatic brain injuries, and intracerebral hemorrhages, which is projected to upsurge the demand for cranial perforators. According to the World Health Organization, around 50 million people have epilepsy, making it one of the most common neurological diseases globally.
The global cranial perforators market is segmented on the type, and end-user. Based on the type, the market is sub-segmented into reusable cranial perforators and disposable cranial perforators. Further, based on the end-user, the market is sub-segmented into hospitals and ambulatory surgical centers. Among the type, the disposable cranial perforators sub-segment is anticipated to hold a considerable share of the market, owing to the eliminating the risk of cross-contamination and infection transmission, saving valuable operating room time compared to reusable cranial perforators that require reprocessing.
Among the product, the hospitals sub-segment is expected to hold a considerable share of the global cranial perforators market. The hospitals segment accounted for the largest market share of 60.4% in 2022. This is due to the increasing hospitalization of patients with neurological disease conditions. According to the National Center for Biotechnology Information (NCBI), each year, 22.6 million people suffer from neurological injuries or disorders, of whom 13.8 million need surgery for their treatment. Thus, the increasing number of neurological hospital admission boost the demand for devices required for surgery, thereby driving segment growth. The availability of technologically advanced cranial perforators, coupled with favorable reimbursement policies, can further enhance segment growth during the forecast period.
The global cranial perforators market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the increasing technologically advanced cranial perforators, coupled with favorable reimbursement policies, rising prevalence and incidence of diseases that require surgery.
Among all regions, North America is anticipated to hold a prominent share over the forecast period. The market growth is attributed to the rising incidence of neurological disorders, advancements in surgical techniques, the rising geriatric population, and continuous R&D in neurosurgical procedures. Moreover, regulatory approvals, favorable reimbursement policies, and healthcare infrastructure significantly contribute to the market's expansion. According to the Brain Aneurysm Foundation, an estimated 6.7 million people in the US have an unruptured brain aneurysm or 1 in 50 people. Ruptured brain aneurysms account for 3-5% of all new strokes. The region's advanced medical research landscape fosters collaborations between medical device manufacturers, research institutions, and healthcare providers. These partnerships drive innovation in cranial perforators, with an emphasis on personalized medicine and patient-specific instruments.
The major companies serving the global cranial perforators market include: ACRA-CUT Inc., American Surgical Co., Integra LifeSciences Corp., Nouvag AG, adeor medical AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2020, adeor medical AG entered into partnership with IMEDCARE to exclusively distribute products in Australia through Imedcare.